It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The Obama administration has proposed regulatory changes in payment for Medicare Part B drugs. They’re looking to impose a broad, multi-year change through a demonstration project.
Medicare demonstrations routinely test payment or delivery models in pilot programs, make a report to Congress, and the lawmakers either enact or reject the model as a statutory basis for Medicare payment.
But Obama’s proposal goes well beyond a normal pilot program, testing to see what does and doesn’t work among a relatively small, randomly selected, group of providers.
From Obama & ABC's HealthCare propaganda show...Obama's tells woman that maybe her elderly mother shouldn't have received that pacemaker - maybe she should have just taken a pain pill (and died) instead of still being alive at 105 (5 years after her operation)...this is who I want in charge of my healthcare options
The assumption, in any case, is that this will incentivize physicians to use lower cost drugs that are as equally or more effective in improving patient outcomes than higher cost drugs.
One of the biggest problems: China’s government-run health insurance funds, which are struggling to keep up with an ageing population and surging incidence of diseases like cancer or diabetes. As they grapple with tighter budgets and a slowing economy, many of these funds are capping reimbursements to patients and pushing local authorities to negotiate with companies to lower drug prices.
Do you even know what generic medications are?